5-(4-BROMO-PHENYL)-[1,3,4]OXADIAZOLE-2-THIOL(41421-19-6)
- Name: 5-(4-BROMO-PHENYL)-[1,3,4]OXADIAZOLE-2-THIOL
- Synonyms:5-(4-Bromo-phenyl)-[1,3,4]oxadiazole-2-thiol;5-p-bromophenyl-2-mercapto-1,3,4-oxadiazole;5-(4-bromo-phenyl)-3H-[1,3,4]oxadiazole-2-thione;
- Molecular Formula:C8H5BrN2OS
- Molecular Weight:257.111
- CAS Registry Number:41421-19-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.41421-19-6 5-(4-bromophenyl)-1,3,4-oxadiazole-2-thiol
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.41421-19-6 5-(4-Bromo-phenyl)-[1,3,4]oxadiazole-2-thiol
Assay:97% Appearance:off-white powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 628-04-6/ethyl isoamyl ether
- 1576-27-8/3-(4-chlorophenyl)-1-dodecyl-1-methoxyurea
- 1129-26-6/4-METHOXYBENZENESULFONAMIDE
- 94861-34-4/ethyl phenyl[2-(piperidin-1-yl)propyl]carbamate
- 152-84-1/1-hydroxy-2-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]anthraquinone
- 19870-33-8/1-TULIPOSIDEB
- 50856-85-4/1,2-bis(4-methylphenyl)guanidine
- 18991-39-4/4-Methyl Thio Benzyl Cyanide
- 105788-17-8/3-methoxy-4-(pent-4-en-1-yloxy)anilinium bromide
- 4707-36-2/2,3-dihydro-1H-benzo[f]chromen-1-one
- 132901-24-7/2,2-(1,6-Hexanediyl)bis(5-fluoro-4(1H)-pyrimidinone)
- 10324-17-1/4-(2-methylacryloyl)benzoic acid
- 144304-58-5/Phenol, 4,4-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane, methyloxirane, methyloxirane polymer with oxirane ether with 1,2,3-propanetriol (3:1), and oxirane
- 215867-95-1/Emecorrugatin A
- 62891-63-8/1,3-Isobenzofurandione, 5,5'-carbonylbis-, polymer with 4,4'-methylenebis[benzenamine] and 3,3'-(1,1,3,3-tetramethyl-1,3-disiloxanediyl)bis[1-propanamine]
- 58090-43-0/N-[1,1-bis(hydroxymethyl)propyl]-2,2-bis(4-chlorophenoxy)acetamide
- 68309-96-6/Dihydroxymono(ethylacetoacetato)aluminum
- 28822-73-3/DL-3,4-DIHYDROXYPHENYL GLYCOL
- 4293-61-2/4-ethyl-2-methyl-4,5-dihydrothiazole
- 41421-19-6/5-(4-BROMO-PHENYL)-[1,3,4]OXADIAZOLE-2-THIOL
- 61653-39-2/(E)-1-phenyl-2-[4-(propan-2-yl)phenyl]diazene
- 93628-82-1/0-13-00-00471 (Beilstein Handbook Reference)
- 174158-75-9/1H-Indene-4,6-diol,2-[(2R,3R)-3-(3,5- dihydroxyphenyl)-2,3-dihydro-6-hydroxy-2- (4-hydroxyphenyl)-4-benzofuranyl]-2,3- dihydro-1-[(S)-hydroxy(4-hydroxyphenyl)- methyl]-3-(4-hydroxyphenyl)-,(1S,2R,3S)-
- 109640-80-4/Spiro[5H-[1]benzopyrano[2,3-d]pyrimidine-5,1'(3'H)-isobenzofuran]-3'-one,7-(dibutylamino)-8-(diethylamino)-4-methyl-
- 74401-77-7/1-[(3,5-dimethoxyphenyl)carbonyl]-3,3-diethylpyridine-2,4(1H,3H)-dione
- 126861-32-3/8-(1-methylethyl)-11-oxo-N-2H-tetrazol-5-yl-11H-pyrido[2,1-b]quinazoline-2-carboxamide
- 105913-11-9/delta(2-89)-tissue plasminogen activator
- 10023-86-6/Butanamide,2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-
- 121608-29-5/(5Z)-1-(2,3-dichlorophenyl)-3-(4-morpholin-4-ylphenyl)-5-[(3-nitrophenyl)methylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
- 64358-66-3/2-{[cyclohexyl(methyl)phenylsilyl]oxy}-N,N-diethylethanamine